K Maeda

507 total citations
29 papers, 374 citations indexed

About

K Maeda is a scholar working on Pharmacology, Molecular Biology and Mechanical Engineering. According to data from OpenAlex, K Maeda has authored 29 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Mechanical Engineering. Recurrent topics in K Maeda's work include Microbial Natural Products and Biosynthesis (6 papers), Cavitation Phenomena in Pumps (4 papers) and Coal Combustion and Slurry Processing (4 papers). K Maeda is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Cavitation Phenomena in Pumps (4 papers) and Coal Combustion and Slurry Processing (4 papers). K Maeda collaborates with scholars based in Japan and Ireland. K Maeda's co-authors include Hitoshi Umezawa, Yoshirō Okami, Tsutomu Takeuchi, RYOZO UTAHARA, Mitsuharu Ueda, K Yagishita, Shinichi Kondo, Shuji HATTORI, Toru Takita and Hajime Yamaguchi and has published in prestigious journals such as Marine Ecology Progress Series, Japanese Journal of Applied Physics and Wear.

In The Last Decade

K Maeda

28 papers receiving 347 citations

Peers

K Maeda
Comparison fields: 5 of 95
  • Molecular Biology 149
  • Pharmacology 140
  • Organic Chemistry 87
  • Infectious Diseases 73
  • Epidemiology 43
Replace J. P. Rosselet with:
J. P. Rosselet United States
P. W. Ensminger United States
Susanne Mayer Germany
Elizabeth Bugie United States
C J Boylan United States
Philippe Dehottay Belgium
Sang Kyun Ahn Canada
Heriberto Rivera United States
Alexandre Famechon France
Christine Sizemore United States
J. P. Rosselet United States View profile →
Citations per field, relative to K Maeda
K Maeda · 1×
Citations per year, relative to K Maeda
K Maeda · 1×

Countries citing papers authored by K Maeda

Since Specialization
Citations

This map shows the geographic impact of K Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Maeda more than expected).

Fields of papers citing papers by K Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Maeda. The network helps show where K Maeda may publish in the future.

Co-authorship network of co-authors of K Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of K Maeda. A scholar is included among the top collaborators of K Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Maeda. K Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 5
3 1
4 11
5 2
6 1
7 13
8 5
9 1
10 2
11 1
12
Chemical studies on kasugamycin. IV. Synthetic transformations of kasuganobiosamine to kasugamycinic acid, isokasugamycinic acid, and their amides.
4
13
New antibiotics, ilamycins.
27
14
Chemical studies on antibiotics of Streptomyces. VI. Chemistry on sarkomycin.
2
15
Cyanomycin, a new antibiotic.
4
16
Structural studies on griseolutein B, phenazine antibiotic.
1
17
Studies on antibiotic actinomycetes. VII. Azomycin-producing strain resembling to Nocardia mesenterica.
7
18
Chemical studies on antibiotic substances. IV. A crystalline toxic substance of Streptomyces thioluteus producing aureothricin.
18
19
A new antibiotic, azomycin.
57
20
An antibiotic, phthiomycin.
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026